Comparative Immunogenicity and Efficacy of Thermostable (Lyophilized) and Liquid Formulation of Anthrax Vaccine Candidate AV7909

The anthrax vaccine candidate AV7909 is being developed as a next-generation vaccine for a post-exposure prophylaxis (PEP) indication against anthrax. AV7909 consists of the anthrax vaccine adsorbed (AVA) (Emergent BioSolutions Inc., Lansing, MI) bulk drug substance adjuvanted with the immunostimula...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Vaccine
Egile Nagusiak: Smiley, M. Autumn, Sanford, Daniel C., Triplett, Cheryl A., Callahan, Daniel, Frolov, Vladimir, Look, Jee, Ruiz, Christian, Reece, Joshua J., Miles, Aaron, Ruiz, Ericka, Ionin, Boris, Shearer, Jeffry D., Savransky, Vladimir
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2019
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6764848/
https://ncbi.nlm.nih.gov/pubmed/31530467
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2019.09.015
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak